COCRYSTAL PHARMA, INC. Increase (Decrease) in Deferred Liabilities
COCRYSTAL PHARMA, INC. (COCP) reported Increase (Decrease) in Deferred Liabilities of -$21.00 thousand for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredLiabilities · last filed 2018-11-09
- COCRYSTAL PHARMA, INC. increase (decrease) in deferred liabilities for the quarter ending 2017-03-31 was -$16.00K.
- COCRYSTAL PHARMA, INC. increase (decrease) in deferred liabilities for the quarter ending 2016-12-31 was $9.00K.
- COCRYSTAL PHARMA, INC. increase (decrease) in deferred liabilities for the quarter ending 2016-09-30 was -$3.00K.
- COCRYSTAL PHARMA, INC. increase (decrease) in deferred liabilities for the quarter ending 2016-06-30 was -$2.00K.
- COCRYSTAL PHARMA, INC. increase (decrease) in deferred liabilities for fiscal 2016 was $2.00K.
| Period end | Increase (Decrease) in Deferred Liabilities 3 month | Increase (Decrease) in Deferred Liabilities 6 month | Increase (Decrease) in Deferred Liabilities 9 month | Increase (Decrease) in Deferred Liabilities 12 month |
|---|---|---|---|---|
| 2018-09-30 | -$21.00K 10-Q · filed 2018-11-09 | |||
| 2017-09-30 | -$14.00K 10-Q · filed 2018-11-09 | |||
| 2017-03-31 | -$16.00K 10-Q · filed 2017-05-10 | -$7.00K derived: sum of 2 quarters · filed 2017-05-10 | -$10.00K derived: sum of 3 quarters · filed 2017-05-10 | -$12.00K derived: sum of 4 quarters · filed 2017-05-10 |
| 2016-12-31 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $6.00K derived: sum of 2 quarters · filed 2017-03-31 | $4.00K derived: sum of 3 quarters · filed 2017-03-31 | $2.00K 10-K · filed 2017-03-31 |
| 2016-09-30 | -$3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$5.00K derived: sum of 2 quarters · filed 2016-11-09 | -$7.00K 10-Q · filed 2016-11-09 | |
| 2016-06-30 | -$2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$4.00K 10-Q · filed 2016-08-09 | ||
| 2016-03-31 | -$2.00K 10-Q · filed 2017-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |